Adupa P Rao, MD

Title(s)Clinical Associate Professor of Medicine (Clinician Educator)
SchoolKeck School of Medicine of Usc
AddressIRD 720 2020 Zonal Avenue
Off Campus
Los Angeles CA 90033
Phone+1 323 226 7923
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Pasadena Magazine2011Top Doctor
    1987Tutor of the Year
    1998Resident of the Year
    GlaxoSmithKline2001Fellowship Research Award
    1998Chief Resident of Internal Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Rao attended the University of Southern California as an undergraduate before returning to his native India for medical school. After receiving his medical degree, Dr. Rao was welcomed back to USC and completed an internship, a residency and two fellowships at the LAC+USC Medical Center. An expert in Cystic Fibrosis, Dr. Rao has taught several courses to medical students on understanding the disease and is the Associate Director of the Keck School of Medicine’s Adult Cystic Fibrosis Program.

    Dr. Rao’s research activities include lung transplantation and Cystic Fibrosis: Testosterone, Rate of PFT Decline. He has also been a distinguished lecturer on Sarcoidosis and created a DVD produced by the Cystic Fibrosis Foundation titled “Looking Ahead: Transition for Pediatric to Adult Cystic Fibrosis Patient Care.”

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients. Pharmaceutics. 2023 May 08; 15(5). Hong E, Carmanov E, Shi A, Chung PS, Rao AP, Forrester K, Beringer PM. PMID: 37242680; PMCID: PMC10222456.
      View in: PubMed   Mentions: 3  
    2. Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series. Pharmacotherapy. 2023 04; 43(4):291-299. Hong E, Li R, Shi A, Almond LM, Wang J, Khudari AZ, Haddad S, Sislyan S, Angelich M, Chung PS, Rao AP, Beringer PM. PMID: 36866442.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19. Clin Pharmacol Ther. 2022 06; 111(6):1324-1333. Hong E, Almond LM, Chung PS, Rao AP, Beringer PM. PMID: 35292968; PMCID: PMC9087007.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    4. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis. Antimicrob Agents Chemother. 2018 09; 62(9). Park AYJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. PMID: 29914949; PMCID: PMC6125567.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    5. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis. Antimicrob Agents Chemother. 2017 10; 61(10). Bensman TJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. PMID: 28784670; PMCID: PMC5610479.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    6. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation. Antimicrob Agents Chemother. 2017 08; 61(8). Bensman TJ, Jayne JG, Sun M, Kimura E, Meinert J, Wang JC, Schaal JB, Tran D, Rao AP, Akbari O, Selsted ME, Beringer PM. PMID: 28559270; PMCID: PMC5527632.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    7. Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells. Pulm Pharmacol Ther. 2012 Oct; 25(5):377-82. Bensman TJ, Nguyen AN, Rao AP, Beringer PM. PMID: 22771903.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros. 2009 Jan; 8(1):19-25. Beringer PM, Hidayat L, Heed A, Zheng L, Owens H, Benitez D, Rao AP. PMID: 18799365.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    9. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. J Clin Pharmacol. 2008 Aug; 48(8):957-65. Liu S, Beringer PM, Hidayat L, Rao AP, Louie S, Burckart GJ, Shapiro B. PMID: 18511651.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    Adupa's Networks
    Concepts (87)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.